Live Chat

Berdagang AstraZeneca AZN

AstraZeneca carta live

Wawasan

Weekly Search
Weekly
Daily
date Tutup change Perubahan (%): Buka Tinggi Rendah

Markets.com news

New Zealand dollar drops on unexpected dovish tone from RBNZ
Georgy Istigechev 2024 Jul 10, 10:00

Unexpected dovish tone from RBNZ drops New Zealand dollar

Forex Indices USD
Sterling steady as investors take in UK, French election results
Georgy Istigechev 2024 Jul 09, 10:15

Sterling steady near one-month high in wake of UK election

Forex Indices GBP USD EUR
BP shares fall on Q2 profit warning
Georgy Istigechev 2024 Jul 09, 10:00

BP shares drop over 4% on Q2 lower profit warning

Shares Indices Oil FTSE100
BP shares dip ahead of Powell Congress testimony
Neil Wilson 2024 Jul 09, 07:30

BP dips, Powell Congress speech ahead, records for Tokyo, NY

Shares Indices Forex Commodities

Maklumat

Sebaran nilai

68.43

Spread (%)

0.6598 %

Leveraj

1:5

Faedah semalaman (Beli)

-0.0590 %

Faedah semalaman (Jual)

-0.0299 %

Mata wang

PNC

Waktu perdagangan

Pasaran ditutup

Selasa

08:01 - 11:59

Isnin

08:01-11:59

Isnin

12:03-16:29

Rabu

08:01-11:59

Rabu

12:03-16:29

Khamis

08:01-11:59

Khamis

12:03-16:29

Jumaat

08:01-11:59

Jumaat

12:03-16:29

Penyata Pendapatan

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

161574354944

Saham Tertunggak

1550320000

Tarikh Pendapatan (Seterusnya)

0000-00-00

instr__dividend_date

instr__ex_dividend_date

2024-08-08

instr__forward_annual_dividend_rate

2.34

instr__forward_annual_dividend_yield

0.0228

EPS

3.26

Saham Tertunggak

AstraZeneca AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Ketahui lebih lanjut mengenai instrumen ini

Instrumen Berkaitan
Trustpilot
Live Chat